DongKoo Bio & Pharma Co. Ltd. (006620) — Cash Flow Quality Index
DongKoo Bio & Pharma Co. Ltd. (006620) has a Cash Flow Quality Index of 0.12x as of December 2025. Operating cash flow of ₩5.15 Billion is below net income of ₩41.27 Billion, suggesting accrual-heavy earnings not yet converted to cash. Explore 006620 debt coverage from operations to assess how comfortably operating cash covers total debt obligations.
Cash Flow Quality Index
Operating Cash Flow
Net Income
Data as of
DongKoo Bio & Pharma Co. Ltd. Cash Flow Quality Index (2015–2025)
Historical Cash Flow Quality Index for DongKoo Bio & Pharma Co. Ltd. across 11 annual periods. Values consistently above 1.0x indicate high-quality earnings. For the full cash flow conversion analysis, see DongKoo Bio & Pharma Co. Ltd. cash conversion from operations.
Annual Cash Flow Quality Index for DongKoo Bio & Pharma Co. Ltd. (2015–2025)
Year-by-year earnings quality comparison for DongKoo Bio & Pharma Co. Ltd..
| Year | Quality Index | Operating CF (KRW) | Net Income | YoY Change |
|---|---|---|---|---|
| 2025 | -0.09x | ₩-4.29 Billion | ₩50.27 Billion | ▼ -101.0% |
| 2024 | 8.71x | ₩17.34 Billion | ₩1.99 Billion | ▲ +2769.4% |
| 2023 | 0.30x | ₩3.59 Billion | ₩11.81 Billion | ▼ -88.1% |
| 2022 | 2.54x | ₩16.82 Billion | ₩6.61 Billion | ▲ +32.5% |
| 2021 | 1.92x | ₩17.90 Billion | ₩9.33 Billion | ▲ +134.3% |
| 2020 | 0.82x | ₩7.49 Billion | ₩9.14 Billion | ▲ +22.0% |
| 2019 | 0.67x | ₩10.14 Billion | ₩15.10 Billion | ▲ +487.8% |
| 2018 | -0.17x | ₩-791.20 Million | ₩4.57 Billion | ▼ -119.9% |
| 2017 | 0.87x | ₩9.51 Billion | ₩10.94 Billion | ▼ -24.7% |
| 2016 | 1.15x | ₩12.59 Billion | ₩10.91 Billion | ▼ -33.0% |
| 2015 | 1.72x | ₩6.93 Billion | ₩4.03 Billion | — |